Everolimus Tablets 0.25mg
Categories: , , , , ,
Date:

Everolimus Tablets 0.25mg Technical Specification:

Product Name:Everolimus Tablets 0.25mg
Brand Name:Generics
Strength:0.5mg, 0.25mg, 0.75mg, 5mg, 2.5mg, 7.5mg, 10mg
Dosage Form:Tablets
Packing:7s, 10s, 28s, 30s, 60s
Route of Administration:For Oral Use only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-Cancer
Indication: Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system
Storage:Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Everolimus Tablets 0.25mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Everolimus Tablets 0.25mg
    Each uncoated tablet contains:
    Everolimus…………………..0.25 mg
    Excipients…………………….q.s.

THERAPEUTIC INDICATIONS:

Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system

CAUTION & WARNING:

CAUTION: It is dangerous to take this preparation except under medical supervision.

WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.

WARNING: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of a Cancer Specialist only.

Keep out of reach and sight of children.

Swallow complete tablet, do not crush or chew.

STORAGE & DOSAGE:

Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture.

Dosage: As directed by Oncologist.

For Oral use. Read the package insert before use.

 

GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Everolimus Tablets 0.5mg
b) Everolimus Tablets 0.25mg
c) Everolimus Tablets 0.75mg
d) Everolimus Tablets 5mg
e) Everolimus Tablets 2.5mg
f) Everolimus Tablets 7.5mg
g) Everolimus Tablets 10mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Everolimus Tablets 0.5mg
Each uncoated tablet contains:
Everolimus…………………..0.5 mg
Excipients…………………….q.s.

b) Everolimus Tablets 0.25mg
Each uncoated tablet contains:
Everolimus………………..0.25 mg
Excipients………………….q.s.

c) Everolimus Tablets 0.75mg
Each uncoated tablet contains:
Everolimus…………………0.75 mg
Excipients………………….q.s.

d) Everolimus Tablets 5mg
Each uncoated tablet contains:
Everolimus……………………..5 mg
Excipients……………………….q.s.

e) Everolimus Tablets 2.5mg
Each uncoated tablet contains:
Everolimus…………………..2.5 mg
Excipients……………………q.s.

f) Everolimus Tablets 7.5mg
Each uncoated tablet contains:
Everolimus…………………..7.5 mg
Excipients…………………….q.s.

g) Everolimus Tablets 10 mg
Each uncoated tablet contains:
Everolimus……………………10 mg
Excipients……………………..q.s.

THERAPEUTIC INDICATIONS:

Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system

CAUTION & WARNING:

CAUTION: It is dangerous to take this preparation except under medical supervision.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
WARNING: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of a Cancer Specialist only.
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.

STORAGE & DOSAGE:

Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture.
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.